“Duodenal trauma is a rare occurrence existing in 1–4.7% of all abdominal trauma. Its posterior and partially retroperitoneal location shields it from most traumatic mechanisms. Colloquially referred to as the ‘surgical soul’, its proximity to complex regional anatomy makes duodenal trauma particularly at risk for biliary, pancreatic and major vascular injury with 68–86.5% of patients sustaining an associated injury.”
“Preoperative (neoadjuvant) chemotherapy and radiotherapy are substantially more effective than similar postoperative therapy in oesophageal, gastric, and rectal cancer. Earlier treatment might be more effective at eradicating micrometastatic disease than the same treatment 3 months later, the typical period between diagnosis and starting postoperative chemotherapy, particularly because surgery increases growth factor activity in the early postoperative period, promoting more rapid tumour progression.”
“The overall incidence of duodenal injuries in severely injured trauma patients is between 0.2 to 0.6% and the overall prevalence in those suffering from abdominal trauma is 3 to 5% 1,2. Approximately 80% of these cases are secondary to penetrating trauma, commonly associated with vascular and adjacent organ injuries. These associated injuries create a significant challenge towards the early diagnosis and appropriate management. Therefore, defining the best surgical treatment algorithm remains controversial. Mild to moderate duodenal trauma is currently manage via primary repair and simple surgical techniques. However, severe injuries have required complex surgical techniques (duodenal diverticulization, pyloric exclusion with or without gastrojejunostomy and pancreatoduodenectomy) without significant favorable outcomes and consequential increase in the rates of mortality.”
| Topic | Articles |
| Kidney | Lentine KL, et al. OPTN/SRTR 2020 Annual Data Report: Kidney. Am J Transplant. 2022 Mar;22 Suppl 2:21-136. Vincenti F, Charpentier B, Vanrenterghem Y, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant. 2010 Mar;10(3):535-46. doi: 10.1111/j.1600-6143.2009.03005.x. PMID: 20415897. |
| Liver | Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996 Mar 14;334(11):693-9. PMID: 8594428. |
| Immuno-suppression |
| Topic | Articles |
| Lung Cancer | Eby ME, Seder CW. The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer. Ann Surg Oncol. 2020 Aug;27(8):3030-3036. |
| Lung Nodule | |
| Lung Mastectomy | |
| Benign Lung | Rationale and design of The National Emphysema Treatment Trial (NETT): a prospective randomized trial of lung volume reduction surgery. The National Emphysema Treatment Trial Research Group. Chest. 1999 Dec;116(6):1750-61. doi: 10.1378/chest.116.6.1750. PMID: 10593802. Fishman A, Martinez F, et al.; National Emphysema Treatment Trial (NETT) Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003 May 22;348(21):2059-73. doi: 10.1056/NEJMoa030287. PMID: 12759479. |
| Mediastinal Masses | |
| Empyema | |
| Esophageal Cancer | Demarest CT, Chang AC. The Landmark Series: Multimodal Therapy for Esophageal Cancer. Ann Surg Oncol. 2021 Jun;28(6):3375-3382. |
| Topic | Articles |
| Anorectal Malformations | Cairo SB, et al.; Delivery of Surgical Care Committee of the AAP Section on Surgery. Challenges in transition of care for patients with anorectal malformations: a systematic review and recommendations for comprehensive care. Dis Colon Rectum. 2018 Mar;61(3):390-399. Erratum in: Dis Colon Rectum. 2018 May;61(5):e337. |
| Intestinal Failure and Malrotation | Duggan CP, Jaksic T. Pediatric Intestinal Failure. N Engl J Med. 2017 Aug 17;377(7):666-675. |
| Biliary Atresia | |
| EA-TEF | |
| CDH |
Surgical Focus 